- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
Tenosynovitis is a type of immune disorder that affects the tendons and their surrounding sheaths. It is caused by inflammation of the tendon sheath, which can be caused by a variety of factors, including repetitive motion, trauma, and infection. Treatment for tenosynovitis typically involves rest, physical therapy, and medications to reduce inflammation.
The Tenosynovitis Drug market is composed of a variety of medications used to treat the condition. These include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. NSAIDs are used to reduce inflammation and pain, while corticosteroids are used to reduce inflammation and suppress the immune system. Biologics are used to target specific molecules involved in the inflammation process.
The Tenosynovitis Drug market is highly competitive, with a number of companies offering various treatments. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Show Less Read more